When breathing becomes difficult and everyday activities feel exhausting, understanding your treatment options can help you regain control of your life. Chronic obstructive pulmonary disease affects millions worldwide, but advances in medicine continue to offer new ways to manage symptoms, reduce flare-ups, and improve daily comfort.

How Treatment Helps You Breathe Easier

Chronic obstructive pulmonary disease, commonly known as COPD, is a long-term condition that damages the lungs and airways, making it progressively harder to breathe. The disease cannot be cured, but treatment can make a significant difference in how you feel and function every day. The main goals of treatment are to relieve symptoms like shortness of breath and chronic cough, slow down the progression of lung damage, prevent and manage sudden worsening episodes called exacerbations, and help you stay active and maintain your quality of life.^[1][2]

Treatment approaches vary depending on how severe your COPD is, which symptoms trouble you most, and whether you have other health conditions. Some people need only basic medications and lifestyle changes, while others with more advanced disease may require oxygen therapy or specialized rehabilitation programs. What works for one person may not be the best choice for another, which is why healthcare providers carefully evaluate each patient’s situation before recommending a treatment plan.^[3]

Medical societies and expert groups have developed guidelines based on years of research to help doctors choose the most effective treatments. These standard approaches form the foundation of COPD care. At the same time, researchers continue to test new medications and therapies in clinical trials, which are carefully controlled studies designed to determine whether experimental treatments are safe and effective. Some of these promising new approaches may eventually become standard treatment options.^[4][5]

Standard Medications and Therapies

The cornerstone of COPD treatment involves medications delivered through inhalers, small handheld devices that allow medicine to reach directly into your lungs. The most commonly prescribed medications are bronchodilators, which work by relaxing the muscles around your airways. When these muscles relax, the airways open wider, allowing air to flow more easily in and out of your lungs. This makes breathing less laborious and reduces the feeling of breathlessness that many people with COPD experience.^[11][12]

There are two main types of bronchodilators. Beta-2 agonists, such as salbutamol, terbutaline, salmeterol, formoterol, and indacaterol, work by stimulating specific receptors in the airway muscles. Antimuscarinic medications, also called anticholinergics, include ipratropium, tiotropium, glycopyronium, and aclidinium, and they work through a different mechanism by blocking signals that cause airways to tighten. Some bronchodilators are short-acting and work quickly for immediate relief, lasting about four to six hours. Others are long-acting and provide relief for twelve hours or more, so they need to be taken only once or twice daily.^[12][14]

Research has shown that combining two different types of long-acting bronchodilators—a beta-2 agonist with an antimuscarinic—works better than using either medicine alone. This combination therapy, often called LABA/LAMA therapy (short for Long-Acting Beta Agonist and Long-Acting Muscarinic Antagonist), has been shown to reduce exacerbations and hospitalizations more effectively than single-drug treatment. Patients using combination therapy also experience improved breathing and can do more activities with less discomfort. For these reasons, current guidelines recommend combination bronchodilator therapy for people whose symptoms persist despite using a single medication.^[15][18]

When bronchodilators alone do not adequately control symptoms or if a person continues to have frequent exacerbations, doctors may add inhaled corticosteroids to the treatment plan. Corticosteroids are medications that reduce inflammation and swelling in the airways. By calming this inflammation, they can help prevent flare-ups and make breathing easier. Common inhaled corticosteroids used in COPD include medicines that are combined with long-acting bronchodilators in a single inhaler, creating what is known as triple therapy—an inhaled corticosteroid plus two different bronchodilators.^[11][12]

Adding an inhaled corticosteroid to dual bronchodilator therapy does reduce the number of exacerbations people experience. However, it also comes with a trade-off: inhaled corticosteroids increase the risk of developing pneumonia, a serious lung infection. Interestingly, while the risk of pneumonia goes up, the overall rate of hospitalization does not increase with triple therapy. People who have high levels of certain white blood cells called eosinophils in their blood may benefit more from inhaled corticosteroids than those with lower levels, though they also face a greater risk of pneumonia.^[15]

Some people with COPD produce large amounts of thick mucus that is difficult to cough up. For these individuals, a type of medication called a mucolytic may be helpful. Mucolytics such as carbocisteine or acetylcysteine work by thinning the mucus, making it easier to clear from the lungs. These medicines come as tablets, capsules, or powders that are mixed with water and are usually taken several times a day.^[12]

Another medication that may be prescribed is theophylline, a bronchodilator taken as a pill rather than inhaled. Theophylline can help reduce inflammation and relax airway muscles, though exactly how it works is not completely understood. Because the effective dose of theophylline is close to the dose that can cause side effects, people taking this medication often need regular blood tests to ensure the level in their bloodstream stays within a safe range. Common side effects include nausea, vomiting, headaches, trouble sleeping, and irregular heartbeat.^[12]

For people with COPD who have low oxygen levels in their blood, long-term oxygen therapy can be lifesaving. When the oxygen saturation in the blood drops to eighty-eight percent or lower, or when the partial pressure of oxygen falls below fifty-five millimeters of mercury, providing supplemental oxygen for at least fifteen hours a day has been shown to reduce mortality significantly. Studies have found that patients with severe hypoxia who use long-term oxygen therapy live longer than those who do not. The oxygen is delivered through a small tube that sits just inside the nostrils, connected to a portable oxygen tank or concentrator. While this therapy is highly beneficial for people with very low oxygen levels, it does not improve survival in those whose oxygen levels are only mildly reduced.^[15][19]

Pulmonary rehabilitation is a comprehensive program that combines exercise training, education about COPD and how to manage it, nutritional counseling, and sometimes psychological support. These programs are designed to improve physical fitness, teach breathing techniques, and help people understand their medications and when to seek medical help. Pulmonary rehabilitation has been shown to improve quality of life, increase exercise capacity, and reduce hospitalizations. It is one of the most effective non-drug treatments available for COPD.^[11][18][19]

When COPD symptoms suddenly worsen—an event called an exacerbation or flare-up—more intensive treatment is needed. Exacerbations are often triggered by respiratory infections. Treatment typically includes higher doses of bronchodilators, a short course of oral corticosteroids (steroid pills, not inhalers), and sometimes antibiotics if a bacterial infection is suspected. Severe exacerbations may require hospitalization, where patients can receive oxygen, intravenous medications, and close monitoring. Managing exacerbations quickly and effectively is crucial because frequent or severe exacerbations can lead to faster decline in lung function and worsening overall health.^[18]

Importantly, maintenance treatment with oral corticosteroids—taking steroid pills every day for long periods—is not recommended for COPD. Studies have found that this approach does not reduce exacerbations, hospitalizations, or mortality, but it does significantly increase the risk of serious side effects such as bone thinning, high blood sugar, infections, and muscle weakness.^[15]

For a small number of people with very severe emphysema, surgical procedures may be considered. Lung volume reduction surgery involves removing damaged portions of the lung, which can allow the remaining healthier lung tissue to function better. In extremely severe cases, lung transplantation may be an option, though this major procedure carries significant risks and requires lifelong medication to prevent organ rejection. These surgical options are reserved for carefully selected patients who continue to have severe symptoms despite optimal medical treatment.^[11][12]

Innovative Treatments in Clinical Research

While standard treatments help many people with COPD, researchers continue to search for better ways to manage the disease. Clinical trials are studies in which new medications or therapies are tested in people to determine whether they are safe and effective. These studies follow strict protocols and are carefully monitored to protect participants. Clinical trials proceed through several phases: Phase I trials primarily test safety and determine the appropriate dose in a small number of people; Phase II trials evaluate whether the treatment works and continue to assess safety in a larger group; and Phase III trials compare the new treatment against current standard treatments in an even larger population to confirm effectiveness and monitor for side effects.^[18]

One area of research focuses on drugs called PDE4 inhibitors. These medications work by blocking an enzyme called phosphodiesterase-4, which plays a role in inflammation. By inhibiting this enzyme, PDE4 inhibitors can reduce inflammation in the airways and may help prevent exacerbations. While some PDE4 inhibitors have been approved for use in certain countries, research continues to refine these treatments and develop newer versions with fewer side effects.^[11]

Scientists are also investigating biologic therapies, which are medications made from living cells or organisms that target very specific parts of the immune system. Some biologics aim to reduce certain types of inflammation that contribute to COPD, particularly in patients who have features of both COPD and asthma. These therapies are still being studied to determine which patients might benefit most and how safe they are for long-term use.

Clinical trials for COPD are conducted around the world, including in the United States, Europe, and other regions. Each trial has specific criteria for who can participate, usually based on the severity of COPD, age, smoking history, and other health conditions. People interested in participating in a clinical trial should discuss the option with their healthcare provider, who can help them understand the potential benefits and risks and determine whether they meet the eligibility criteria for any available studies.

Most Common Treatment Methods

• Short-acting Bronchodilators
  • Beta-2 agonist inhalers like salbutamol and terbutaline provide quick relief of breathlessness
  • Antimuscarinic inhalers such as ipratropium work through a different mechanism to open airways
  • Can be used up to four times daily when symptoms occur
  • Each dose lasts approximately four to six hours
• Long-acting Bronchodilators
  • Beta-2 agonists including salmeterol, formoterol, and indacaterol last at least twelve hours
  • Antimuscarinic medications like tiotropium, glycopyronium, and aclidinium provide long-lasting airway opening
  • Taken once or twice daily for continuous symptom control
  • Combination LABA/LAMA therapy reduces exacerbations better than single medications
• Inhaled Corticosteroids
  • Reduce inflammation and swelling in airways
  • Usually prescribed as part of combination inhalers with long-acting bronchodilators
  • Triple therapy includes an inhaled steroid plus two different bronchodilators
  • Can reduce exacerbations but may increase risk of pneumonia
• Mucolytic Medications
  • Carbocisteine and acetylcysteine thin thick mucus in the lungs
  • Make it easier to cough up phlegm and clear airways
  • Taken as tablets, capsules, or powder mixed with water
  • Usually taken three or four times daily
• Oxygen Therapy
  • Prescribed for patients with severe hypoxia (oxygen saturation of eighty-eight percent or lower)
  • Should be used at least fifteen hours per day for maximum benefit
  • Delivered through nasal tubes connected to portable tanks or concentrators
  • Significantly reduces mortality in people with very low oxygen levels
• Pulmonary Rehabilitation
  • Structured programs combining exercise training and education
  • Teaches breathing techniques and medication management
  • Includes nutritional counseling and psychological support
  • Improves quality of life and reduces hospitalizations
• Surgical Procedures
  • Lung volume reduction surgery removes damaged lung tissue in severe emphysema
  • Lung transplantation reserved for extremely severe cases
  • Only considered for carefully selected patients who continue to have severe symptoms despite optimal medical treatment